Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.
about
Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.Liver Failure due to Acute Viral Hepatitis (A-E)Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-AnalysisThe HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-AnalysisHepatitis VaccinesHepatitis B virus and hepatitis C virus infection in healthcare workersMetabonomic window into hepatitis B virus-related hepatic diseasesControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaNaturally derived anti-hepatitis B virus agents and their mechanism of actionThe Role of Immune Cells in Chronic HBV InfectionUpdate on hepatitis B and C virus diagnosisPrevention of infection-related cancers in the WHO Western Pacific RegionApplication of CRISPR/Cas9 Technology to HBVProphylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus InfectionHepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendationsEarly-life exposures to infectious agents and later cancer developmentVaccination of healthcare workers: A reviewHepatitis B and A vaccination in HIV-infected adults: A reviewTherapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuckNTCP and beyond: opening the door to unveil hepatitis B virus entryPrevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in NepalHepatitis B virus infection and risk of coronary artery disease: a meta-analysisHepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protectionHepatocellular carcinoma: a reviewDiagnosis of hepatitis BThe clinical implications of hepatitis B virus genotypes and HBeAg in pediatricsFunction and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver DiseaseViral hepatitis screening guideline before biological drug use in rheumatic patientsFuture Therapy for Hepatitis B Virus: Role of ImmunomodulatorsSeroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countriesEfficacy and safety of tenofovir in chronic hepatitis B: Australian real world experienceSpatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean BasinSubgenotypes and mutations in the s and polymerase genes of hepatitis B virus carriers in the West Bank, palestineGenomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practiceMicrofibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient CohortDNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B VirusEnigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter?Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytesGenome-wide identification of direct HBx genomic targets
P2860
Q26740195-6FFAA64C-3A7D-42DD-B161-0FDC7B222370Q26740326-A76FB177-908D-4CDB-BC9E-8D9EFB316618Q26743423-E6D1A7E6-776A-4FC3-8ADB-68448843CDB3Q26745887-3F4560F5-96F9-4F56-9B5B-CCE61288DC36Q26765433-8B932E92-7FD6-4FD8-B76E-728291DE2C55Q26765801-4FAA78FD-593A-4BD9-A0CF-B051F73EC818Q26771253-B22E30FF-D08F-480B-B78E-77C3A0C3D635Q26772324-86FD2290-11A1-48C4-9FBE-20AA29F32D17Q26772336-299A79CD-F8E4-49D7-A166-0FEAB87B1DDCQ26774875-C3A4051D-8FB8-4B9D-84A5-69730B2BC6EEQ26777048-FE9A0311-49F6-48C2-8629-499DB66F858BQ26777318-465EBF42-3554-4DD7-8DC0-5385E327909BQ26779150-FE087A61-5AEA-4897-8A85-E9CD49396B87Q26781880-0DD6C3C5-EBDC-439E-A7CF-912F327A9CB0Q26781962-949DDD64-5FF6-4686-BDCF-80890AC72C6DQ26784247-AB56AE89-4069-4310-A957-5D642313CFC5Q26786103-07C1ABD7-3B16-4FB6-B8E8-7E4984191EB4Q26796300-BC02BDDA-6397-4769-87C0-5BBA44297931Q26799782-270CD217-499D-4273-970D-FF63BB4BCC48Q26828598-E5657A2F-C452-4A3E-ABA6-6AB3775F7F2BQ26999712-AB5C217D-3876-473E-BB80-C894A4B21C3AQ27303069-2D05A49F-D04F-405B-878C-0E350B6F2683Q28068804-E289001D-1D3A-4AF2-B0AB-0BFE308F0564Q28069273-F67C6D57-4138-49BA-A05F-EBB28100E086Q28069290-12186F6E-BDBC-4261-A6EB-B24683320797Q28071817-861D16C3-9A38-48CF-9514-BB59E5B1D3D2Q28073299-705A89EC-F95D-40FC-911F-1CF064F49FF9Q28073703-323D7AC0-56FC-4541-B1BA-7DE9D8F925A3Q28076767-FDBE5B89-69A7-4ECE-B771-453D88DC05DDQ28078148-D1AC6F7E-BEB7-4616-9731-06636FC3F3F7Q28078813-47ECE83E-1193-45E0-9D6E-F366BFF91E1DQ28468387-4C436CB0-F420-4A8D-99CA-D968A712800CQ28483949-CAFD106C-BE65-406F-A77C-06831272B4B3Q28542694-9B76FCCF-69B0-4BD3-BF84-A3718F59DBE7Q28543022-B9433B35-4372-4121-96B4-017D694790B2Q28550209-FB2DED46-7C80-4B7B-B0A0-31AF84D603A1Q28552967-BB079906-FE32-4D81-9A92-BDE2155398FEQ28657724-DBA8FAB1-857D-41E5-8296-54173EDD490BQ28676360-FCEFF7A1-EF2C-4030-A0C7-8D17E60B564FQ29048191-6BBC75D3-0747-43B2-A879-77B166598814
P2860
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Global epidemiology of hepatit ...... seroprevalence and endemicity.
@en
Global epidemiology of hepatit ...... seroprevalence and endemicity.
@nl
type
label
Global epidemiology of hepatit ...... seroprevalence and endemicity.
@en
Global epidemiology of hepatit ...... seroprevalence and endemicity.
@nl
prefLabel
Global epidemiology of hepatit ...... seroprevalence and endemicity.
@en
Global epidemiology of hepatit ...... seroprevalence and endemicity.
@nl
P2093
P1433
P1476
Global epidemiology of hepatit ...... seroprevalence and endemicity.
@en
P2093
P304
P356
10.1016/J.VACCINE.2011.12.116
P407
P577
2012-01-24T00:00:00Z